Lipoprotein (a): impact by ethnicity and environmental and medical conditions

• Main Authors: Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
• Format: Article
• Language: English
• Published: Elsevier 2016-07-01
• Series: Journal of Lipid Research
• Subjects: populations; apolipoprotein (a) size; genetics; demographic and clinical characteristics; kidney and liver disease; diabetes
• Online Access: http://www.sciencedirect.com/science/article/pii/S002222752035149X

Levels of lipoprotein (a) [Lp(a)], a complex between an LDL-like lipid moiety containing one copy of apoB, and apo(a), a plasminogen-derived carbohydrate-rich hydrophilic protein, are primarily genetically regulated. Although stable intra-individually, Lp(a) levels have a skewed distribution inter-individually and are strongly impacted by a size polymorphism of the LPA gene, resulting in a variable number of kringle IV (KIV) units, a key motif of apo(a). The variation in KIV units is a strong predictor of plasma Lp(a) levels resulting in stable plasma levels across the lifespan. Studies have demonstrated pronounced differences across ethnicities with regard to Lp(a) levels and some of this difference, but not all of it, can be explained by genetic variations across ethnic groups. Increasing evidence suggests that age, sex, and hormonal impact may have a modest modulatory influence on Lp(a) levels. Among clinical conditions, Lp(a) levels are reported to be affected by kidney and liver diseases.